BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 35764499)

  • 1. Defective VWF secretion due to expression of MYH9-RD E1841K mutant in endothelial cells disrupts hemostasis.
    Cao Y; Sun Y; Deng Y; Wei G; Liu J; Jin S; Dong C; Kang X; Huo Y; Zhang J; Luo J
    Blood Adv; 2022 Aug; 6(15):4537-4552. PubMed ID: 35764499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myosin IIa is critical for cAMP-mediated endothelial secretion of von Willebrand factor.
    Li P; Wei G; Cao Y; Deng Q; Han X; Huang X; Huo Y; He Y; Chen L; Luo J
    Blood; 2018 Feb; 131(6):686-698. PubMed ID: 29208598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Megakaryocyte migration defects due to nonmuscle myosin IIA mutations underlie thrombocytopenia in MYH9-related disease.
    Pal K; Nowak R; Billington N; Liu R; Ghosh A; Sellers JR; Fowler VM
    Blood; 2020 May; 135(21):1887-1898. PubMed ID: 32315395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonmuscle Myosin Heavy Chain IIA Mutation Predicts Severity and Progression of Sensorineural Hearing Loss in Patients With MYH9-Related Disease.
    Verver EJ; Topsakal V; Kunst HP; Huygen PL; Heller PG; Pujol-Moix N; Savoia A; Benazzo M; Fierro T; Grolman W; Gresele P; Pecci A
    Ear Hear; 2016; 37(1):112-20. PubMed ID: 26226608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonmuscle myosin heavy chain IIA mutations define a spectrum of autosomal dominant macrothrombocytopenias: May-Hegglin anomaly and Fechtner, Sebastian, Epstein, and Alport-like syndromes.
    Heath KE; Campos-Barros A; Toren A; Rozenfeld-Granot G; Carlsson LE; Savige J; Denison JC; Gregory MC; White JG; Barker DF; Greinacher A; Epstein CJ; Glucksman MJ; Martignetti JA
    Am J Hum Genet; 2001 Nov; 69(5):1033-45. PubMed ID: 11590545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Megakaryocyte-restricted MYH9 inactivation dramatically affects hemostasis while preserving platelet aggregation and secretion.
    Léon C; Eckly A; Hechler B; Aleil B; Freund M; Ravanat C; Jourdain M; Nonne C; Weber J; Tiedt R; Gratacap MP; Severin S; Cazenave JP; Lanza F; Skoda R; Gachet C
    Blood; 2007 Nov; 110(9):3183-91. PubMed ID: 17664350
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Cechova S; Dong F; Chan F; Kelley MJ; Ruiz P; Le TH
    J Am Soc Nephrol; 2018 Jan; 29(1):155-167. PubMed ID: 28993503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Zyxin regulates endothelial von Willebrand factor secretion by reorganizing actin filaments around exocytic granules.
    Han X; Li P; Yang Z; Huang X; Wei G; Sun Y; Kang X; Hu X; Deng Q; Chen L; He A; Huo Y; Li D; Betzig E; Luo J
    Nat Commun; 2017 Mar; 8():14639. PubMed ID: 28256511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations in non-muscle myosin 2A disrupt the actomyosin cytoskeleton in Sertoli cells and cause male infertility.
    Sung DC; Ahmad M; Lerma Cervantes CB; Zhang Y; Adelstein RS; Ma X
    Dev Biol; 2021 Feb; 470():49-61. PubMed ID: 33188738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MYH9-related disease: a novel prognostic model to predict the clinical evolution of the disease based on genotype-phenotype correlations.
    Pecci A; Klersy C; Gresele P; Lee KJ; De Rocco D; Bozzi V; Russo G; Heller PG; Loffredo G; Ballmaier M; Fabris F; Beggiato E; Kahr WH; Pujol-Moix N; Platokouki H; Van Geet C; Noris P; Yerram P; Hermans C; Gerber B; Economou M; De Groot M; Zieger B; De Candia E; Fraticelli V; Kersseboom R; Piccoli GB; Zimmermann S; Fierro T; Glembotsky AC; Vianello F; Zaninetti C; Nicchia E; Güthner C; Baronci C; Seri M; Knight PJ; Balduini CL; Savoia A
    Hum Mutat; 2014 Feb; 35(2):236-47. PubMed ID: 24186861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mouse models of MYH9-related disease: mutations in nonmuscle myosin II-A.
    Zhang Y; Conti MA; Malide D; Dong F; Wang A; Shmist YA; Liu C; Zerfas P; Daniels MP; Chan CC; Kozin E; Kachar B; Kelley MJ; Kopp JB; Adelstein RS
    Blood; 2012 Jan; 119(1):238-50. PubMed ID: 21908426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations responsible for MYH9-related thrombocytopenia impair SDF-1-driven migration of megakaryoblastic cells.
    Pecci A; Bozzi V; Panza E; Barozzi S; Gruppi C; Seri M; Balduini CL
    Thromb Haemost; 2011 Oct; 106(4):693-704. PubMed ID: 21833445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered cytoskeleton organization in platelets from patients with MYH9-related disease.
    Canobbio I; Noris P; Pecci A; Balduini A; Balduini CL; Torti M
    J Thromb Haemost; 2005 May; 3(5):1026-35. PubMed ID: 15869600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Linking the Landscape of
    Asensio-Juárez G; Llorente-González C; Vicente-Manzanares M
    Cells; 2020 Jun; 9(6):. PubMed ID: 32545517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis and treatment of
    Rabbolini DJ; Chun Y; Latimer M; Kunishima S; Fixter K; Valecha B; Tan P; Chew LP; Kile BT; Burt R; Radhakrishnan K; Bird R; Ockelford P; Gabrielli S; Chen Q; Stevenson WS; Ward CM; Morel-Kopp MC
    Platelets; 2018 Dec; 29(8):793-800. PubMed ID: 29090586
    [No Abstract]   [Full Text] [Related]  

  • 16. Megakaryocytes of patients with MYH9-related thrombocytopenia present an altered proplatelet formation.
    Pecci A; Malara A; Badalucco S; Bozzi V; Torti M; Balduini CL; Balduini A
    Thromb Haemost; 2009 Jul; 102(1):90-6. PubMed ID: 19572073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical, pathological, and genetic analysis of ten patients with MYH9-related disease.
    Sun XH; Wang ZY; Yang HY; Cao LJ; Su J; Yu ZQ; Bai X; Ruan CG
    Acta Haematol; 2013; 129(2):106-13. PubMed ID: 23207509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contribution of platelet vs. endothelial VWF to platelet adhesion and hemostasis.
    Kanaji S; Fahs SA; Shi Q; Haberichter SL; Montgomery RR
    J Thromb Haemost; 2012 Aug; 10(8):1646-52. PubMed ID: 22642380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myosin Va acts in concert with Rab27a and MyRIP to regulate acute von-Willebrand factor release from endothelial cells.
    Rojo Pulido I; Nightingale TD; Darchen F; Seabra MC; Cutler DF; Gerke V
    Traffic; 2011 Oct; 12(10):1371-82. PubMed ID: 21740491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent advances in the understanding and management of MYH9-related inherited thrombocytopenias.
    Balduini CL; Pecci A; Savoia A
    Br J Haematol; 2011 Jul; 154(2):161-74. PubMed ID: 21542825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.